Henrik Kristian Moltke
Director/Board Member presso INITIATOR PHARMA A/S
Profilo
Henrik Kristian Moltke currently works at Dermaveris ApS, as Chairman, Werner Richter Og Hustrus Legat, as Chairman, StemCare A, as Director, StemCare Danmark A, as Director, Initiator Pharma A, as Independent Director from 2016, and Biosergen AB, as Independent Director from 2021.
Mr. Moltke also formerly worked at EntomoPharm ApS, as Chief Executive Officer, NTG Nordic Transport Group A, as Director-Investor Relations & Communications, Sjælsø Gruppen A, as Director, Hartmanns A, as Director from 1998 to 2022, Astion Pharma A, as Chief Financial Officer & Executive Vice President, Fluxome Sciences A, as Chief Financial Officer, Acesion Pharma ApS, as Chief Financial Officer, Allarity Therapeutics A, as Senior Vice President in 2020, and FluoGuide A, as Chief Financial Officer from 2020 to 2022.
Mr. Moltke received his graduate degree from Copenhagen Business School.
Posizioni attive di Henrik Kristian Moltke
| Società | Posizione | Inizio |
|---|---|---|
| INITIATOR PHARMA A/S | Director/Board Member | 01/01/2016 |
| BIOSERGEN AB | Director/Board Member | 01/01/2021 |
| Dermaveris ApS | Chairman | - |
StemCare A/S
 StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Director/Board Member | - |
| StemCare Danmark A/S | Director/Board Member | - |
| Werner Richter Og Hustrus Legat | Chairman | - |
Precedenti posizioni note di Henrik Kristian Moltke
| Società | Posizione | Fine |
|---|---|---|
| FLUOGUIDE A/S | Director of Finance/CFO | 15/11/2022 |
Hartmanns A/S
 Hartmanns A/S Personnel ServicesCommercial Services Hartmanns A/S produces molded fiber packaging. The company is headquartered in Ballerup, Denmark. | Director/Board Member | 01/06/2022 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director of Finance/CFO | 04/11/2020 |
| ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
Formazione di Henrik Kristian Moltke
| Copenhagen Business School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| INITIATOR PHARMA A/S | Health Technology |
| FLUOGUIDE A/S | Health Technology |
| BIOSERGEN AB | Health Technology |
| Aziende private | 11 |
|---|---|
Sjælsø Gruppen A/S
 Sjælsø Gruppen A/S Financial ConglomeratesFinance Sjælsø Gruppen A/S engages in the trade and investment activities related to real estate. The firm develops real estate properties and also leases businesses, retail, and residential projects for owners, tenants, and investors. The company was founded by Ib Henrik Ronje and Torben Ronje on October 1, 1977 and is headquartered in Allerød, Denmark. | Finance |
Astion Pharma A/S
 Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Health Technology |
Fluxome Sciences A/S
 Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Health Technology |
StemCare A/S
StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Health Technology |
Hartmanns A/S
Hartmanns A/S Personnel ServicesCommercial Services Hartmanns A/S produces molded fiber packaging. The company is headquartered in Ballerup, Denmark. | Commercial Services |
EntomoPharm ApS
 EntomoPharm ApS Pharmaceuticals: MajorHealth Technology EntomoPharm ApS is a holding company that develops insect based absorption, distribution, metabolism, or excretion (ADME) models for early drug discovery. It is a contract research organization that offers validated ex vivo blood brain barrier screening model providing customized study design. Its insect assays can be used to screen small-molecule compounds to identify properties of drug leads in both central nervous system drug development and in safety risk identification for peripherally acting drugs. The firm provides models based on the locust migratory to determine the permeability; the in vivo and the ex vivo model. The company was founded by Peter Aadal Nielsen and Gunnar Andersson in 2009 and is headquartered in Hillerod, Denmark. | Health Technology |
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Dermaveris ApS | |
| StemCare Danmark A/S | |
| Werner Richter Og Hustrus Legat | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Henrik Kristian Moltke
